A clinical trial to evaluate the effect of statin use on lowering aldosterone levels

BACKGROUND: Statins are the first-line pharmaceutical agent in the management of hypercholesterolemia and cardiovascular (CV) risk reduction, and the most commonly prescribed class of drugs worldwide. Studies describing CV risk reduction independent of LDL-cholesterol lowering have evoked an interes...

Descripción completa

Detalles Bibliográficos
Autores principales: Hornik, Ezra S., Altman-Merino, Anne E., Koefoed, Andrew W., Meyer, Kayla M., Stone, Isabella B., Green, Jessica A., Williams, Gordon H., Adler, Gail K., Williams, Jonathan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362429/
https://www.ncbi.nlm.nih.gov/pubmed/32664962
http://dx.doi.org/10.1186/s12902-020-00587-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362429/
https://www.ncbi.nlm.nih.gov/pubmed/32664962
http://dx.doi.org/10.1186/s12902-020-00587-4

Ejemplares similares